英国NIBSC标准品是深圳远扬化学技术有限公司的热销产品，主要应用在哪些领域呢？
英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的药品控制实验室(OMCL)。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。
NIBSC 战略目标：对有关生物产品的问题给出回复和建议；提供生物药品方面的国家科技力量，维持满足科学和药物学领域新发展需求的灵活性、专业知识和设施；
作为化验方法（如量化生物学活性以及确定生物产品特征和进行安全评估）方面的机构运营并得到认同；
在欧洲生物产品的控制和标准化方面，继续发挥科学基础开发的中心作用；
在生物药品法规的科学方面帮助社会达成共识，并籍于此，与世界卫生组织紧密合作；
在控制和标准化的关键领域实现和维护质量鉴定。
生物药品控制
药品中使用的生物物质包括病毒和细菌疫苗、从人类血液提取的产物、荷尔蒙以及其它诸如细胞分裂素和生长素等治疗药物。
这些生物物质对药物学和公众健康做出了巨大贡献并发挥着越来越大的作用，它们大大改善了*的疾病预防、诊断和治疗。
英国NIBSC标准品部分产品列表：
（篇幅有限，更多产品，欢迎进入我司展台查询）
| 01/491 | Meningococcal serogroup W polysaccharide |
| 13/240 | Influenza Antigen B/Massachusetts/02/2118 (Egg derived) |
| 12/B623-034 | QCRFLUAH1N1QC1-Influenza AH1N1 QC32 |
| 95/634 | Interleukin-95 (Human, rDNA derived) |
| 10/211 | Reteplase Reference Material |
| 12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
| 13/242 | Polio Anti Sabin type 25 (inactivated) Serum |
| 95/587 | Interleukin-48 (Human, rDNA derived) |
| 10/107 | Reteplase Reference Material |
| 13/202 | C-Peptide, Human. 57st International Standard. |
| 95/644 | Interleukin-105 (Human, rDNA derived) |
| 12/B623-096 | QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
| 13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
| 95/556 | Interleukin-17 (Human, rDNA derived) |
| 13/317 | Polio Anti Sabin type 100 (inactivated) Serum |
| 95/562 | Interleukin-23 (Human, rDNA derived) |
| 12/B623-077 | QCRFLUAH1N1QC1-Influenza AH1N1 QC75 |
| 12/B623-033 | QCRFLUAH1N1QC1-Influenza AH1N1 QC31 |
| 13/165 | C-Peptide, Human. 20st International Standard. |
| 13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
| 01/520 | Meningococcal serogroup W polysaccharide |
| 10/207 | Reteplase Reference Material |
| 03/104-065 | HTLV-50 (antibody) Monitor Sample |
| 12/B623-098 | QCRFLUAH1N1QC1-Influenza AH1N1 QC96 |
| 13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
| 03/104-034 | HTLV-19 (antibody) Monitor Sample |
| 01/478 | Meningococcal serogroup W polysaccharide |
| 95/659 | Interleukin-120 (Human, rDNA derived) |
| 95/592 | Interleukin-53 (Human, rDNA derived) |
| 95/579 | Interleukin-40 (Human, rDNA derived) |
| 13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
| 07/339 | BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
| 95/565 | Interleukin-26 (Human, rDNA derived) |
| 01/429 | Meningococcal serogroup W polysaccharide |
| 01/441 | Meningococcal serogroup W polysaccharide |
| 12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
| 10/116 | Reteplase Reference Material |
| 12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
| 10/156 | Reteplase Reference Material |
| 07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
| 12/B623-020 | QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
| 01/497 | Meningococcal serogroup W polysaccharide |
| 13/174 | C-Peptide, Human. 29st International Standard. |
| 13/196 | Influenza Antigen B/Massachusetts/02/2074 (Egg derived) |
| 12/B623-062 | QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
| 10/193 | Reteplase Reference Material |
| 13/143 | Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
| 07/381 | BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent) |
| 01/528 | Meningococcal serogroup W polysaccharide |
| 03/104-074 | HTLV-59 (antibody) Monitor Sample |
| 01/507 | Meningococcal serogroup W polysaccharide |
| 01/526 | Meningococcal serogroup W polysaccharide |
| 13/167 | Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
| 01/530 | Meningococcal serogroup W polysaccharide |
| 13/193 | Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
| 03/104-118 | HTLV-103 (antibody) Monitor Sample |
| 03/104-069 | HTLV-54 (antibody) Monitor Sample |
| 03/104-083 | HTLV-68 (antibody) Monitor Sample |
| 07/318 | BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent) |
| 12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
| 10/210 | Reteplase Reference Material |
| 13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
| 10/140 | Reteplase Reference Material |
| 07/291 | BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent) |
| 13/183 | Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
| 13/224 | Influenza Antigen B/Massachusetts/02/2102 (Egg derived) |
| 10/104 | Reteplase Reference Material |
| 10/200 | Reteplase Reference Material |
| 13/245 | C-Peptide, Human. 100st International Standard. |
| 03/104-043 | HTLV-28 (antibody) Monitor Sample |
| 07/361 | BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
| 01/513 | Meningococcal serogroup W polysaccharide |
| 03/104-120 | HTLV-105 (antibody) Monitor Sample |
| 13/209 | C-Peptide, Human. 64st International Standard. |
| 03/104-018 | HTLV-3 (antibody) Monitor Sample |
| 95/618 | Interleukin-79 (Human, rDNA derived) |
| 07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
| 10/201 | Reteplase Reference Material |
| 12/B623-027 | QCRFLUAH1N1QC1-Influenza AH1N1 QC25 |
| 07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
| 12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
| 13/187 | Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
| 13/306 | Polio Anti Sabin type 89 (inactivated) Serum |
| 03/104-108 | HTLV-93 (antibody) Monitor Sample |
| 07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |
| 13/158 | C-Peptide, Human. 13st International Standard. |
| 12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
| 07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
| 13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
| 03/104-089 | HTLV-74 (antibody) Monitor Sample |
| 13/172 | C-Peptide, Human. 27st International Standard. |
| 13/224 | C-Peptide, Human. 79st International Standard. |
| 01/512 | Meningococcal serogroup W polysaccharide |
| 01/469 | Meningococcal serogroup W polysaccharide |
| 13/235 | C-Peptide, Human. 90st International Standard. |
| 12/B623-082 | QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
| 13/151 | C-Peptide, Human. 6st International Standard. |
| 13/211 | C-Peptide, Human. 66st International Standard. |
| 01/436 | Meningococcal serogroup W polysaccharide |
| 10/135 | Reteplase Reference Material |
| 03/104-032 | HTLV-17 (antibody) Monitor Sample |
| 95/630 | Interleukin-91 (Human, rDNA derived) |
| 07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
| 13/240 | Polio Anti Sabin type 23 (inactivated) Serum |
| 95/608 | Interleukin-69 (Human, rDNA derived) |
| 13/315 | Polio Anti Sabin type 98 (inactivated) Serum |
| 95/614 | Interleukin-75 (Human, rDNA derived) |
| 07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
| 07/336 | BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
| 13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
| 07/307 | BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
| 03/104-092 | HTLV-77 (antibody) Monitor Sample |
| 95/629 | Interleukin-90 (Human, rDNA derived) |
| 13/226 | Polio Anti Sabin type 9 (inactivated) Serum |
| 01/532 | Meningococcal serogroup W polysaccharide |
| 07/345 | BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent) |
| 01/476 | Meningococcal serogroup W polysaccharide |
| 03/104-101 | HTLV-86 (antibody) Monitor Sample |
| 13/216 | C-Peptide, Human. 71st International Standard. |
| 13/324 | Polio Anti Sabin type 107 (inactivated) Serum |
| 07/275 | BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent) |
| 13/226 | Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
| 03/104-024 | HTLV-9 (antibody) Monitor Sample |
| 01/468 | Meningococcal serogroup W polysaccharide |
| 07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
| 12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
| 12/B623-047 | QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
| 13/271 | Polio Anti Sabin type 54 (inactivated) Serum |
| 95/610 | Interleukin-71 (Human, rDNA derived) |
| 01/450 | Meningococcal serogroup W polysaccharide |
| 07/279 | BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
| 01/442 | Meningococcal serogroup W polysaccharide |
| 12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
| 10/136 | Reteplase Reference Material |
| 12/B623-006 | QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
| 07/351 | BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
| 13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
| 13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
| 03/104-091 | HTLV-76 (antibody) Monitor Sample |
| 01/471 | Meningococcal serogroup W polysaccharide |
| 13/181 | C-Peptide, Human. 36st International Standard. |
| 03/104-095 | HTLV-80 (antibody) Monitor Sample |
| 10/110 | Reteplase Reference Material |
| 10/143 | Reteplase Reference Material |
| 13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
| 07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
| 07/304 | BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent) |
| 13/242 | C-Peptide, Human. 97st International Standard. |
| 12/B623-017 | QCRFLUAH1N1QC1-Influenza AH1N1 QC15 |
| 07/321 | BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent) |
| 10/115 | Reteplase Reference Material |
| 13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
| 12/B623-029 | QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
| 10/165 | Reteplase Reference Material |
| 13/218 | C-Peptide, Human. 73st International Standard. |
| 12/B623-070 | QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
| 13/200 | Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
| 03/104-084 | HTLV-69 (antibody) Monitor Sample |
| 95/624 | Interleukin-85 (Human, rDNA derived) |
| 01/499 | Meningococcal serogroup W polysaccharide |
| 03/104-098 | HTLV-83 (antibody) Monitor Sample |
| 13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
| 01/516 | Meningococcal serogroup W polysaccharide |
| 13/162 | C-Peptide, Human. 17st International Standard. |
| 13/152 | Influenza Antigen B/Massachusetts/02/2030 (Egg derived) |
